Efficacy of intravitreal aflibercept treatment of pigment epithelial detachment in neovascular age-related macular degeneration refractory to intravitreal ranibizumab: 2-year outcomes

被引：0
|
作者：
Ramskold, Louise [1 ]
Lee, Han Bin [1 ]
Chandran, Manju N. [1 ]
Gencheva, Petya [1 ]
Menon, Geeta [1 ]
机构：
[1] Frimley Pk Hosp, Ophthalmol, Frimley, Surrey, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration
    Gary K. Y. Lee
    Timothy Y. Y. Lai
    Wai-Man Chan
    Dennis S. C. Lam
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 1225 - 1227
  • [32] Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
    Thi Ha Chau Tran
    Dumas, Stephane
    Coscas, Florence
    [J]. JOURNAL OF OPHTHALMOLOGY, 2017, 2017
  • [33] Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration
    Venzara, Frank
    Mason, John
    Glover, Jay
    McGwin, Gerald
    Huisingh, Carrie
    Friedman, Duncan
    Feist, Richard
    Thomley, Martin
    Albert, Michael
    Price, Natalie
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [34] RANIBIZUMAB AND AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Data from an Observational Study
    Vaze, Anagha
    Vuong Nguyen
    Daien, Vincent
    Arnold, Jennifer J.
    Young, Stephanie H.
    Cheung, Chui M.
    Lamoureux, Ecosse
    Bhargava, Mayuri
    Barthelmes, Daniel
    Gillies, Mark C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (10): : 1954 - 1961
  • [35] PIGMENT EPITHELIAL DETACHMENT RESPONSE TO AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO RANIBIZUMAB Time Course and Drug Effects
    De Massougnes, Sophie
    Dirani, Ali
    Ambresin, Aude
    Decugis, Doris
    Marchionno, Laetitia
    Mantel, Irmela
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (05): : 881 - 888
  • [36] Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration
    Sizmaz, Selcuk
    Esen, Ebru
    Isik-Ericek, Puren
    Demircan, Nihal
    [J]. CLINICAL AND EXPERIMENTAL OPTOMETRY, 2022, 105 (01) : 55 - 60
  • [37] Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration
    Chang, Andrew A.
    Li, Haitao
    Broadhead, Geoffrey K.
    Hong, Thomas
    Schlub, Timothy E.
    Wijeyakumar, Wijeyanthy
    Zhu, Meidong
    [J]. OPHTHALMOLOGY, 2014, 121 (01) : 188 - 192
  • [38] Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age-related macular degeneration patients
    Kwon, Y. H.
    Min, J. S.
    Ahn, H.
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94
  • [39] Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
    Freund, K. Bailey
    Hoang, Quan V.
    Saroj, Namrata
    Thompson, Desmond
    [J]. OPHTHALMOLOGY, 2015, 122 (09) : 1802 - 1810
  • [40] INTRAVITREAL AFLIBERCEPT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION RESISTANT TO INTRAVITREAL RANIBIZUMAB
    Narayan, Daniel
    Muecke, James
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 119 - 119
12345